Research peptide encyclopedia
Neutral, in-vitro / preclinical profiles of research peptides, plus a live scientific search across the PubMed literature. For laboratory research only.
Research axes
Explore research peptides by area to find compounds relevant to your field of study.
Metabolic
Peptides studied in research on metabolism, lipid oxidation and appetite regulation.
Growth hormone
Compounds studied on GH secretion, IGF-1 pathways and anabolic signalling.
Tissue repair
Peptides studied on the repair of tissues, tendons, ligaments and wound healing.
Cognition & focus
Compounds studied on cognition, neuroprotection and synaptic plasticity.
Longevity & anti-ageing
Peptides studied on cellular senescence, telomeres and markers of ageing.
Skin & hair
Peptides studied on skin, collagen, hair and cutaneous anti-ageing.
Hormonal balance
Peptides studied on hormonal balance and the reproductive axis.
Immunity
Peptides studied on immune modulation and the body's defences.
Scientific search engine
Live results from PubMed (NCBI). Research literature only — no medical advice.
Bremelanotide.
— · 2012
Bremelanotide: First Approval.
Dhillon S, et al. · Drugs · 2019
Bremelanotide for Treatment of Female Hypoactive Sexual Desire.
Edinoff AN, et al. · Neurology international · 2022
Bremelanotide.
— · 2006
Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder.
Mayer D, et al. · The Annals of pharmacotherapy · 2020
Bremelanotide (Vyleesi) for hypoactive sexual desire disorder.
— · The Medical letter on drugs and therapeutics · 2019
Bremelanotide and flibanserin for low sexual desire in women: the fallacy of regulatory precedent.
Mintzes B, et al. · Drug and therapeutics bulletin · 2021
Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder.
Spielmans GI, et al. · Journal of sex research · 2024
Safety Profile of Bremelanotide Across the Clinical Development Program.
Clayton AH, et al. · Journal of women's health (2002) · 2022
An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder.
Cipriani S, et al. · Expert opinion on pharmacotherapy · 2023
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
Kingsberg SA, et al. · Obstetrics and gynecology · 2019
The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.
Pfaus JG, et al. · CNS spectrums · 2022
Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women.
Spielmans GI · Journal of sex research · 2021
Bremelanotide: the female Viagra?
— · Expert review of endocrinology & metabolism · 2006
Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment.
Pettigrew JA, et al. · Journal of midwifery & women's health · 2021
Peptide profiles

BPC-157
A pentadecapeptide studied in preclinical tissue-repair research.
Read
TB-500
A synthetic fragment related to Thymosin Beta-4, studied in cell-migration research.
Read
GHK-Cu
A copper tripeptide (Gly-His-Lys) studied in in-vitro dermatological research.
Read
AHK-Cu
A copper tripeptide (Ala-His-Lys) studied in vitro on the hair follicle.
Read
Reta-R3
A multi-receptor research compound studied in a metabolic context.
Read
Ipamorelin
A peptide studied in vitro as a selective ghrelin-receptor agonist.
Read
CJC-1295 no DAC
A GHRH analogue studied in vitro for the growth-hormone pathway.
Read
PT-141
A peptide studied in vitro as a melanocortin-receptor agonist.
Read
Selank
A synthetic tuftsin analogue studied in vitro as a nootropic peptide.
Read
Tirzepatide
A research peptide studied in vitro as a dual GLP-1 / GIP agonist.
Read
Semaglutide
A research peptide studied in vitro as a GLP-1 receptor agonist.
ReadPeptide directory
A broad index of research peptides — class-level descriptors, each linking to the PubMed literature. Research use only.
| Peptide | Category | Structure | Research application | PubMed |
|---|---|---|---|---|
| BPC-157 | Tissue repair | Pentadecapeptide (15 aa) | Studied in preclinical / in-vitro research on tissue repair. | View |
| TB-500 | Tissue repair | Thymosin β4 fragment | Studied in preclinical / in-vitro research on cell migration. | View |
| GHK-Cu | Skin & hair | Copper tripeptide (Gly-His-Lys) | Studied in preclinical / in-vitro research on the extracellular matrix. | View |
| AHK-Cu | Skin & hair | Copper tripeptide (Ala-His-Lys) | Studied in preclinical / in-vitro research on the hair follicle. | View |
| Reta-R3 | Metabolic | Triple-receptor agonist (investigational) | Studied in preclinical / in-vitro research on metabolism. | View |
| Semaglutide | Metabolic | GLP-1 receptor agonist | Studied in preclinical / in-vitro research on metabolism. | View |
| Tirzepatide | Metabolic | Dual GIP/GLP-1 agonist | Studied in preclinical / in-vitro research on metabolism. | View |
| Cagrilintide | Metabolic | Amylin analogue | Studied in preclinical / in-vitro research on metabolism. | View |
| Survodutide | Metabolic | Dual GLP-1/glucagon agonist (investigational) | Studied in preclinical / in-vitro research on metabolism. | View |
| AOD-9604 | Metabolic | hGH fragment (176-191) | Studied in preclinical / in-vitro research on lipid metabolism. | View |
| MOTS-c | Metabolic | Mitochondrial-derived peptide | Studied in preclinical / in-vitro research on energy metabolism. | View |
| CJC-1295 | Growth hormone | GHRH analogue | Studied in preclinical / in-vitro research on GH secretion. | View |
| Ipamorelin | Growth hormone | Pentapeptide (ghrelin agonist) | Studied in preclinical / in-vitro research on GH secretion. | View |
| GHRP-2 | Growth hormone | GH-releasing hexapeptide | Studied in preclinical / in-vitro research on GH secretion. | View |
| GHRP-6 | Growth hormone | GH-releasing hexapeptide | Studied in preclinical / in-vitro research on GH secretion. | View |
| Sermorelin | Growth hormone | GHRH analogue (1-29) | Studied in preclinical / in-vitro research on GH secretion. | View |
| Tesamorelin | Growth hormone | GHRH analogue | Studied in preclinical / in-vitro research on metabolism and GH. | View |
| Hexarelin | Growth hormone | Hexapeptide (ghrelin agonist) | Studied in preclinical / in-vitro research on GH secretion. | View |
| IGF-1 LR3 | Growth hormone | Long-acting IGF-1 analogue | Studied in preclinical / in-vitro research on anabolic signalling (in vitro). | View |
| MK-677 (Ibutamoren) | Growth hormone | GH secretagogue (GHS-R agonist) | Studied in preclinical / in-vitro research on GH secretion. | View |
| Semax | Cognition & focus | Synthetic heptapeptide (ACTH-derived) | Studied in preclinical / in-vitro research on neuroprotection. | View |
| Selank | Cognition & focus | Synthetic heptapeptide (tuftsin-derived) | Studied in preclinical / in-vitro research on anxiolytic effects. | View |
| Cerebrolysin | Cognition & focus | Neurotrophic peptide mixture | Studied in preclinical / in-vitro research on neuroprotection. | View |
| Dihexa | Cognition & focus | Hexapeptide (angiotensin IV-derived) | Studied in preclinical / in-vitro research on synaptogenesis. | View |
| P-21 (P021) | Cognition & focus | CNTF-derived peptide | Studied in preclinical / in-vitro research on neurogenesis. | View |
| Epithalon | Longevity & anti-ageing | Tetrapeptide (Ala-Glu-Asp-Gly) | Studied in preclinical / in-vitro research on telomeres and ageing. | View |
| FOXO4-DRI | Longevity & anti-ageing | FOXO4-p53 interaction inhibitor peptide | Studied in preclinical / in-vitro research on cellular senescence. | View |
| Humanin | Longevity & anti-ageing | Mitochondrial-derived peptide | Studied in preclinical / in-vitro research on cytoprotection. | View |
| Thymalin | Immunity | Thymic peptide | Studied in preclinical / in-vitro research on immune modulation. | View |
| Thymosin Alpha-1 | Immunity | Thymic peptide (28 aa) | Studied in preclinical / in-vitro research on immune modulation. | View |
| LL-37 | Immunity | Antimicrobial peptide (cathelicidin) | Studied in preclinical / in-vitro research on innate immunity. | View |
| KPV | Immunity | Tripeptide (Lys-Pro-Val) | Studied in preclinical / in-vitro research on inflammation (in vitro). | View |
| ARA-290 (Cibinetide) | Tissue repair | EPO-derived peptide (11 aa) | Studied in preclinical / in-vitro research on anti-inflammation and neuroprotection. | View |
| PT-141 (Bremelanotide) | Hormonal balance | Cyclic melanocortin peptide | Studied in preclinical / in-vitro research on melanocortin receptors. | View |
| Kisspeptin-10 | Hormonal balance | Regulatory decapeptide | Studied in preclinical / in-vitro research on the reproductive axis. | View |
| Oxytocin | Hormonal balance | Nonapeptide (neurohormone) | Studied in preclinical / in-vitro research on social behaviour. | View |
| Melanotan II | Skin & hair | α-MSH analogue heptapeptide | Studied in preclinical / in-vitro research on melanocortin receptors. | View |
| SNAP-8 | Skin & hair | Octapeptide (acetyl octapeptide-3) | Studied in preclinical / in-vitro research on the appearance of wrinkles (in vitro). | View |
| PAL-GHK | Skin & hair | Palmitoylated tripeptide | Studied in preclinical / in-vitro research on collagen (in vitro). | View |
39 / 39 peptides · links to PubMed literature.
Research peptides — Research Use Only
- Not for human consumption
- Not for the diagnosis, treatment or prevention of any disease
